Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in non-diabetic obese pregnant women
IRCT20250111064345N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity comparing Metformin with Placebo (2 arms). Primary endpoints: Total antioxidant capacity of plasma, Serum nitrate and nitrite levels and 4 more. Started Nov 2025; status: completed.
02
Drugs
metformin
03
Conditions
obesity
Beyond the preview
Go deeper on IRCT20250111064345N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250111064345N1.